ANPEP and cancer: Thus, NGR peptide, which is composed of asparagine-glycine-arginine amino acids, has emerged as a promising target molecule for this CD13/APN receptor found in the tumoral microenvironment, because it binds specifically to cancer cells and not to other CD13 rich tissues [144].